Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder

ClinicalTrials.gov ID: NCT01273376

Public ClinicalTrials.gov record NCT01273376. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 12, 2026, 2:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether RX-10100 are effective in the treatment of Major Depressive Disorder (MDD).

Study identification

NCT ID
NCT01273376
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Rexahn Pharmaceuticals, Inc.
Industry
Enrollment
314 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2010
Primary completion
Aug 31, 2011
Completion
Sep 30, 2011
Last update posted
Nov 18, 2013

2010 – 2011

United States locations

U.S. sites
44
U.S. states
20
U.S. cities
41
Facility City State ZIP Site status
Rexahn Investigative Site Cerritos California 90703
Rexahn Investigative Site Escondido California 92025
Rexahn Investigative Site Los Angeles California 90024
Rexahn Investigative Site National City California 91950
Rexahn Investigative Site Oceanside California 92056
Rexahn Investigative Site Orange California 92868
Rexahn Investigative Site San Diego California 92123
Rexahn Investigative Site Denver Colorado 82039
Rexahn Investigative Site Brooksville Florida 34601
Rexahn Investigative Site Gainesville Florida 32607
Rexahn Investigative Site Jacksonville Florida 32216
Rexahn Investigative Site Miami Beach Florida 33139
Rexahn Investigative Site Orlando Florida 32806
Rexahn Investigative Site St. Petersburg Florida 33709
Rexahn Investigative Site Tampa Florida 33606
Rexahn Investigative Site -2 Atlanta Georgia 30328
Rexahn Investigative Site Atlanta Georgia 30328
Rexahn Investigative Site Oak Brook Illinois 60523
Rexahn Investigative Site Vernon Hills Illinois 60061
Rexahn Investigative Site Owensboro Kentucky 42301
Rexahn Investigative Site Novi Michigan 48377
Rexahn Investigative Site Las Vegas Nevada 89146
Rexahn Investigative site Cherry Hill New Jersey 08002
Rexahn Investigative Site Albuquerque New Mexico 87109
Rexahn Investigative Site Fresh Meadows New York 11366
Rexahn Investigative Site New York New York 10021
Rexahn Investigative Site Cincinnati Ohio 45227
Rexahn Investigative site Garfield Heights Ohio 44125
Rexahn Investigative Site Oklahoma City Oklahoma 73103
Rexahn Investigative site Allentown Pennsylvania 18103
Rexahn Investigative Site Media Pennsylvania 19063
Rexahn Investigative Site Scranton Pennsylvania 18503
Rexahn Investigative Site Anderson South Carolina 29621
Rexahn Investigative Site Memphis Tennessee 38119
Rexahn Investigative Site Austin Texas 78756
Rexahn Investigative site Dallas Texas 75231
Rexahn Investigative Site Dallas Texas 75390
Rexahn Investigative Sites Lake Jackson Texas 77566
Rexahn Investigative Site San Antonio Texas 78229
Rexahn Investigative Site The Woodlands Texas 77381
Rexahn Investigative Site Orem Utah 84058
Rexahn Investigative Site Richmond Virginia 23284
Rexahn Investigative Site (2) Bellevue Washington 98007
Rexahn Investigative Site Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01273376, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2013 · Synced Sep 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01273376 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →